AMH在多囊卵巢综合征中的研究进展

被引：28

作者：

陈洁

陈晨

机构：

[1] 上海交通大学医学院附属瑞金医院妇产科

来源：

生殖医学杂志 | 2017年 / 26卷 / 05期

关键词：

多囊卵巢综合征; 抗苗勒管激素; 高雄激素; 胰岛素抵抗;

D O I：

暂无

中图分类号：

R711.75 [卵巢疾病];

学科分类号：

100211 [妇产科学];

摘要：

多囊卵巢综合征(PCOS)是一种常见的妇科内分泌、代谢紊乱性疾病,同时也是一种生殖障碍性疾病,严重危害女性身心健康,但是其具体发病机制目前仍不明确。越来越多的研究证明,抗苗勒氏管激素(AMH)与卵泡生长发育、卵泡募集与成熟、高雄激素血症、胰岛素抵抗等均具有密切关系,在PCOS的发生发展过程中也具有重要调节作用。因此,本文结合AMH与PCOS的最新研究进行综述,以期探讨二者关系及其潜在发病机制,为PCOS的诊治提供新的思路。

引用

页码：490 / 493

页数：4

共 22 条

[1]

Advanced glycation end-products and insulin signaling in granulosa cells [J].

Diamanti-Kandarakis, Evanthia ;

Chatzigeorgiou, Antonios ;

Papageorgiou, Efstathia ;

Koundouras, Dimitrios ;

Koutsilieris, Michael .

EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (13) :1438-1445

[2]

The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.[J].Xinyu Qi;Yanli Pang;Jie Qiao.European Journal of Obstetrics and Gynecology.2016,

[3]

Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial [J].

Irani, Mohamad ;

Seifer, David B. ;

Grazi, Richard V. ;

Julka, Nitasha ;

Bhatt, Devika ;

Kalgi, Bharati ;

Irani, Sara ;

Tal, Oded ;

Lambert-Messerlian, Geralyn ;

Tal, Reshef .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11) :4307-4314

[4]

Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.[J].Richard Fleming;David B. Seifer;John L. Frattarelli;Jane Ruman.Reproductive BioMedicine Online.2015, 4

[5]

1-h Postprandial glucose level is related to the serum anti-Müllerian hormone level in women with polycystic ovary syndrome.[J].Sungwook Chun.Gynecological Endocrinology.2015, 10

[6]

Polycystic Ovarian Syndrome [J].

Trikudanathan, Subbulaxmi .

MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (01) :221-+

[7]

Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance; androgens; obesity and gonadotrophins.[J].Samantha Cassar;Helena J. Teede;Lisa J. Moran;Anju E. Joham;Cheryce L. Harrison;Boyd J. Strauss;Nigel K. Stepto.Clin Endocrinol.2014, 6

[8]

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer.[J].Nathalie Kersual;Véronique Garambois;Thierry Chardès;Jean-Pierre Pouget;Imed Salhi;Caroline Bascoul-Mollevi;Frédéric Bibeau;Muriel Busson;Henri Vié;Béatrice Clémenceau;Christian K Behrens;Pauline Estupina;André Pèlegrin;Isabelle Navarro-Teulon.mAbs.2014, 5

[9]

Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome [J].

Fonseca, Helena Proni ;

Brondi, Renata Suzuki ;

Piovesan, Fernanda Xavier ;

Miklos, Thomas Gabriel ;

Aldrighi, Jose Mendes .

GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (09) :667-670

[10]

Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS [J].

Irani, Mohamad ;

Minkoff, Howard ;

Seifer, David B. ;

Merhi, Zaher .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :E886-E890

← 1 2 3 →